Christine Pellizzari
2018 - INSMED
In 2018, Christine Pellizzari earned a total compensation of $2M as Chief Legal Officer at INSMED, a 3% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $283,500 |
|---|---|
| Option Awards | $975,001 |
| Salary | $436,110 |
| Stock Awards | $324,978 |
| Other | $11,000 |
| Total | $2,030,589 |
Pellizzari received $975K in option awards, accounting for 48% of the total pay in 2018.
Pellizzari also received $283.5K in non-equity incentive plan, $436.1K in salary, $325K in stock awards and $11K in other compensation.
Rankings
In 2018, Christine Pellizzari's compensation ranked 5,666th out of 14,244 executives tracked by ExecPay. In other words, Pellizzari earned more than 60.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,666 out of 14,244 | 60th |
Division Manufacturing | 2,143 out of 5,765 | 63rd |
Major group Chemicals And Allied Products | 793 out of 2,128 | 63rd |
Industry group Drugs | 662 out of 1,817 | 64th |
Industry Pharmaceutical Preparations | 511 out of 1,391 | 63rd |
Source: SEC filing on April 4, 2019.
Pellizzari's colleagues
We found six more compensation records of executives who worked with Christine Pellizzari at INSMED in 2018.
2018
William Lewis
INSMED
Chief Executive Officer
2018
Roger Adsett
INSMED
Chief Commercial Officer
2018
Paul Streck
INSMED
Chief Medical Officer
2018
Paolo Tombesi
INSMED
Chief Financial Officer
2018
S Schaeffer
INSMED
Chief People Strategy Officer
2018
John Goll
INSMED
Former Principal Financial Officer
News
Science 37 Holdings CEO David Coman's 2022 pay slips 4% to $8.1M
March 20, 2023
Science 37 Holdings CEO David Coman's 2021 pay jumps 656% to $8.4M
March 23, 2022
INSMED CEO William Lewis' 2020 pay slips 14% to $6.2M
April 1, 2021
INSMED CEO William Lewis' 2019 pay jumps 21% to $7.2M
March 31, 2020
INSMED CEO William Lewis' 2018 pay jumps 37% to $5.9M
April 4, 2019